We are live on ! Find out more
JPMIA

J.P. Marvel Investment Advisors Portfolio holdings

AUM $705M
1-Year Est. Return 43.01%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
+43.01%
3 Year Est. Return
+140.86%
5 Year Est. Return
+213.54%
10 Year Est. Return
AUM
$332M
AUM Growth
-$138M
Cap. Flow
-$151M
Cap. Flow %
-45.6%
Top 10 Hldgs %
51.51%
Holding
73
New
Increased
17
Reduced
16
Closed
16

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$225K
2
GS icon
Goldman Sachs
GS
+$74.2K
3
MSFT icon
Microsoft
MSFT
+$73.6K
4
LLY icon
Eli Lilly
LLY
+$52.3K
5
NVDA icon
NVIDIA
NVDA
+$46.1K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$29.6M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.4M
3
AMZN icon
Amazon
AMZN
+$23M
4
BMY icon
Bristol-Myers Squibb
BMY
+$12.2M
5
BAC icon
Bank of America
BAC
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 38.07%
2 Technology 22.11%
3 Financials 16.44%
4 Industrials 7.62%
5 Materials 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
1
Moderna
MRNA
$21.8B
$25.2M 7.58%
65,418
-7
-0% -$2.58K
TMO icon
2
Thermo Fisher Scientific
TMO
$213B
$22.2M 6.69%
38,869
-78
-0.2% -$42.8K
MS icon
3
Morgan Stanley
MS
$324B
$20.6M 6.19%
211,356
+171
+0.1% +$16.9K
NVDA icon
4
NVIDIA
NVDA
$4.67T
$18.8M 5.67%
909,620
+2,220
+0.2% +$46.1K
JPM icon
5
JPMorgan Chase
JPM
$929B
$18.3M 5.52%
111,971
-170
-0.2% -$26.7K
CRL icon
6
Charles River Laboratories
CRL
$11.4B
$14.6M 4.4%
35,378
+80
+0.2% +$33.2K
V icon
7
Visa
V
$709B
$14.3M 4.3%
64,042
+140
+0.2% +$32.8K
LLY icon
8
Eli Lilly
LLY
$1.09T
$13.3M 3.99%
57,390
+212
+0.4% +$52.3K
MSFT icon
9
Microsoft
MSFT
$2.94T
$12.7M 3.81%
44,942
+253
+0.6% +$73.6K
JNJ icon
10
Johnson & Johnson
JNJ
$644B
$11.2M 3.36%
69,120
-50
-0.1% -$8.53K
CSCO icon
11
Cisco
CSCO
$453B
$10.3M 3.09%
188,698
+670
+0.4% +$37.6K
CVS icon
12
CVS Health
CVS
$137B
$10.2M 3.06%
119,896
+33
+0% +$2.76K
LRCX icon
13
Lam Research
LRCX
$322B
$9.7M 2.92%
170,420
-200
-0.1% -$12.2K
DE icon
14
Deere & Co
DE
$167B
$9.58M 2.88%
28,582
-234
-0.8% -$84.3K
GLW icon
15
Corning
GLW
$108B
$9.42M 2.84%
258,201
-140
-0.1% -$5.59K
PFE icon
16
Pfizer
PFE
$144B
$8.86M 2.67%
205,894
+5,084
+3% +$225K
SHW icon
17
Sherwin-Williams
SHW
$84.9B
$7.54M 2.27%
26,942
+77
+0.3% +$22.5K
DHR icon
18
Danaher
DHR
$140B
$7.29M 2.19%
26,993
MDT icon
19
Medtronic
MDT
$113B
$7.18M 2.16%
57,258
+30
+0.1% +$3.88K
CMCSA icon
20
Comcast
CMCSA
$87.2B
$6.31M 1.9%
112,841
-250
-0.2% -$14.6K
INTC icon
21
Intel
INTC
$426B
$6.08M 1.83%
114,068
EOG icon
22
EOG Resources
EOG
$77.3B
$5.87M 1.77%
73,120
-260
-0.4% -$18.9K
PG icon
23
Procter & Gamble
PG
$338B
$5.82M 1.75%
41,651
+11
+0% +$1.56K
RTX icon
24
RTX Corp
RTX
$294B
$5.21M 1.57%
60,615
-70
-0.1% -$5.99K
GT icon
25
Goodyear
GT
$2.08B
$3.73M 1.12%
211,024

Similar funds

J.P. Marvel Investment Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, J.P. Marvel Investment Advisors held 73 positions worth $332M, down 29% from $470M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

J.P. Marvel Investment Advisors withdrew a net $151M in Q3 2021, closing 16 positions and reducing 16 holdings. Its most notable exit was Apple, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, J.P. Marvel Investment Advisors added an estimated $225K to Pfizer.

  • J.P. Marvel Investment Advisors added most to Pfizer in Q3 2021, an estimated $225K increase.
  • J.P. Marvel Investment Advisors's biggest Q3 2021 reduction was Newmont, cutting an estimated $107K.
  • J.P. Marvel Investment Advisors fully exited Apple in Q3 2021, selling an estimated $29.6M.
  • J.P. Marvel Investment Advisors's ten largest holdings make up 52% of its $332M portfolio in Q3 2021.
  • J.P. Marvel Investment Advisors opened 0 new positions and closed 16 in Q3 2021.
  • J.P. Marvel Investment Advisors's portfolio value fell 29% quarter-over-quarter to $332M.

Based on J.P. Marvel Investment Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.